Tyra Biosciences, Inc. (TYRA) › Shareholders' EquityTyra Biosciences, Inc. (TYRA) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$4.74M2020: -$13.64M2021: $301.74M2022: $257.83M2023: $204.26M2024: $343.15M2025: $259.18M$259.18M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$259.18M-24.5%2024$343.15M+68.0%2023$204.26M-20.8%2022$257.83M-14.6%2021$301.74M+2312.5%2020-$13.64M-187.7%2019-$4.74M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share